BeyondSpring Inc. Selling, General and Administrative Expense
BeyondSpring Inc. (BYSI) reported Selling, General and Administrative Expense of $758.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- BeyondSpring Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $758.00K, a 19.96% decline year-over-year.
- BeyondSpring Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $1.16M, a 33.41% decline year-over-year.
- BeyondSpring Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.12M, a 8.55% decline year-over-year.
- BeyondSpring Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $751.00K, a 56.74% decline year-over-year.
- BeyondSpring Inc. selling, general and administrative expense for fiscal 2025 was $4.56M, a 25.42% decline from fiscal 2024.
- BeyondSpring Inc. selling, general and administrative expense for fiscal 2024 was $6.11M, a 21.76% decline from fiscal 2023.
- BeyondSpring Inc. selling, general and administrative expense for fiscal 2023 was $7.81M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $758.00K 10-Q · filed 2026-08-14 | $1.91M 10-Q · filed 2026-08-14 | $3.04M derived: sum of 3 quarters · filed 2026-08-14 | $3.79M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $1.16M 10-Q · filed 2026-05-13 | $2.28M derived: sum of 2 quarters · filed 2026-05-13 | $3.03M derived: sum of 3 quarters · filed 2026-05-13 | $3.98M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.87M derived: sum of 2 quarters · filed 2026-03-25 | $2.82M derived: sum of 3 quarters · filed 2026-08-14 | $4.56M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $751.00K 10-Q · filed 2025-11-12 | $1.70M derived: sum of 2 quarters · filed 2026-08-14 | $3.43M 10-Q · filed 2025-11-12 | $4.66M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $947.00K 10-Q · filed 2026-08-14 | $2.68M 10-Q · filed 2026-08-14 | $3.91M derived: sum of 3 quarters · filed 2026-08-14 | $5.65M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $1.74M 10-Q · filed 2026-05-13 | $2.96M derived: sum of 2 quarters · filed 2026-05-13 | $4.70M derived: sum of 3 quarters · filed 2026-05-13 | $6.51M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.96M derived: sum of 2 quarters · filed 2026-03-25 | $4.78M derived: sum of 3 quarters · filed 2026-03-25 | $6.11M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $1.74M 10-Q · filed 2025-11-12 | $3.55M derived: sum of 2 quarters · filed 2025-11-12 | $4.88M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $1.81M 10-Q · filed 2025-08-13 | $3.15M 10-Q · filed 2025-08-13 | $4.27K 6-K · filed 2024-08-29 | ||
| 2024-03-31 | $1.33M 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | $7.81M 10-K · filed 2025-03-27 | ||||
| 2023-06-30 | $5.14K 6-K · filed 2024-08-29 | $5.14M 6-K · filed 2024-02-02 | |||
| 2022-12-31 | $13.01M 20-F · filed 2023-04-18 | ||||
| 2022-06-30 | $7.49M 6-K · filed 2024-02-02 | ||||
| 2021-12-31 | $5.04M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $15.27M derived: sum of 2 quarters · filed 2023-04-18 | $24.26M derived: sum of 3 quarters · filed 2023-04-18 | $30.70M 20-F · filed 2023-04-18 | |
| 2021-09-30 | $10.23M 6-K · filed 2021-12-30 | $19.21M derived: sum of 2 quarters · filed 2021-12-30 | $25.66M 6-K · filed 2021-12-30 | $36.03M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-06-30 | $8.98M 6-K · filed 2021-09-10 | $15.43M 6-K · filed 2023-02-28 | $25.80M derived: sum of 3 quarters · filed 2023-04-18 | $32.51M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-03-31 | $6.45M 6-K · filed 2021-06-16 | $16.82M derived: sum of 2 quarters · filed 2023-04-18 | $23.53M derived: sum of 3 quarters · filed 2023-04-18 | $26.12M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2020-12-31 | $10.37M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $17.08M derived: sum of 2 quarters · filed 2023-04-18 | $19.67M derived: sum of 3 quarters · filed 2023-04-18 | $22.60M 20-F · filed 2023-04-18 | |
| 2020-09-30 | $6.71M 6-K · filed 2021-12-30 | $9.30M derived: sum of 2 quarters · filed 2021-12-30 | $12.23M 6-K · filed 2021-12-30 | $14.93M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2020-06-30 | $2.59M 6-K · filed 2021-09-10 | $5.52M 6-K · filed 2021-09-10 | $8.22M derived: sum of 3 quarters · filed 2022-04-14 | $10.70M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2020-03-31 | $2.93M 6-K · filed 2021-06-16 | $5.63M derived: sum of 2 quarters · filed 2022-04-14 | $8.11M derived: sum of 3 quarters · filed 2022-04-14 | $10.25M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2019-12-31 | $2.71M derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $5.18M derived: sum of 2 quarters · filed 2022-04-14 | $7.33M derived: sum of 3 quarters · filed 2022-04-14 | $8.96M 20-F · filed 2022-04-14 | |
| 2019-09-30 | $2.47M 6-K · filed 2020-11-17 | $4.62M derived: sum of 2 quarters · filed 2020-11-17 | $6.26M 6-K · filed 2020-11-17 | $8.54M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-06-30 | $2.15M 6-K · filed 2020-09-03 | $3.79M 6-K · filed 2020-09-03 | $6.07M derived: sum of 3 quarters · filed 2021-04-30 | $7.60M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-03-31 | $1.64M 6-K · filed 2020-06-11 | $3.92M derived: sum of 2 quarters · filed 2021-04-30 | $5.45M derived: sum of 3 quarters · filed 2021-04-30 | $6.84M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2018-12-31 | $2.28M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $3.81M derived: sum of 2 quarters · filed 2021-04-30 | $5.20M derived: sum of 3 quarters · filed 2021-04-30 | $5.93M 20-F · filed 2021-04-30 | |
| 2018-09-30 | $1.53M 6-K · filed 2019-12-18 | $2.92M derived: sum of 2 quarters · filed 2019-12-18 | $3.64M 6-K · filed 2019-12-18 | ||
| 2018-06-30 | $1.39M 6-K · filed 2019-09-18 | $2.12M 6-K · filed 2019-09-18 | |||
| 2018-03-31 | $728.00K 6-K · filed 2019-07-10 | ||||
| 2017-12-31 | $9.05M 20-F · filed 2019-04-30 | ||||
| 2016-12-31 | $1.93M 20-F · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |